1
|
Agarwal G, Varghese S, Francis M, Willan J. High prevalence of persistent COVID-19-related health anxiety and social restriction in patients with haematological disorders. Br J Haematol 2023; 202:1065-1070. [PMID: 37408108 DOI: 10.1111/bjh.18960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Revised: 06/17/2023] [Accepted: 06/19/2023] [Indexed: 07/07/2023]
Affiliation(s)
- G Agarwal
- Medical Sciences Division, University of Oxford, Oxford, UK
| | - S Varghese
- Medical Sciences Division, University of Oxford, Oxford, UK
| | - M Francis
- Medical Sciences Division, University of Oxford, Oxford, UK
| | - J Willan
- Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- Department of Haematology, Frimley Health NHS Foundation Trust, Slough, UK
| |
Collapse
|
2
|
Talens A, López-Pintor E, Bejerano M, Guilabert M, Aznar MT, Aznar-Lou I, Lumbreras B. Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics. J Clin Med 2022; 11:jcm11092436. [PMID: 35566561 PMCID: PMC9103306 DOI: 10.3390/jcm11092436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Revised: 04/21/2022] [Accepted: 04/25/2022] [Indexed: 11/29/2022] Open
Abstract
Background: Several factors can influence adherence to orally administered antineoplastics, including fear or anxiety resulting from situations such as the COVID-19 pandemic. The aim of this study was to analyse the influence of these patients’ experiences on adherence to orally administered antineoplastics. Methods: Cross-sectional study in four hospitals including >18 year old cancer patients receiving orally administered antineoplastics during the first half of 2021. Data were collected from medical records and through telephone interviews. Adherence was assessed through the prescription refill records and pill counts. Patients’ fear resulting from the pandemic was assessed by means of a structured questionnaire using a 5-point Likert-type scale. Results: Our sample compr BARCELONAised 268 patients (54% men) with a mean age of 64 years (SD 12). More than 15% had experienced afraid and 5% had experienced a dangerous situation when attending hospital, 17% felt they had received less care, and 30% preferred telepharmacy. Adherence measured by pill count was 69.3% and 95.5% according to prescription refill records. Patients who had experienced fear or anxiety when attending hospital were less adherent (aOR 0.47, 95% CI 0.23−0.96, p = 0.039). Conclusion: The fear experienced by some patients has affected adherence to treatment.
Collapse
Affiliation(s)
- Amparo Talens
- Servicio de Farmacia, Hospital General Universitario de Elda, 03600 Alicante, Spain; (A.T.); (M.B.)
| | - Elsa López-Pintor
- Departamento de Ingeniería, Área de Farmacia y Tecnología Farmacéutica, Universidad Miguel Hernández, 03550 Alicante, Spain;
- Center for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, Spain;
| | - Marta Bejerano
- Servicio de Farmacia, Hospital General Universitario de Elda, 03600 Alicante, Spain; (A.T.); (M.B.)
| | - Mercedes Guilabert
- Departamento de Psicología de la Salud, Universidad Miguel Hernández, 03202 Alicante, Spain;
| | - María Teresa Aznar
- Servicio de Farmacia, Hospital Universitario San Juan de Alicante, 03550 Alicante, Spain;
| | - Ignacio Aznar-Lou
- Center for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, Spain;
- Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu (IRSJD), 08830 Barcelona, Spain
| | - Blanca Lumbreras
- Center for Biomedical Research in Epidemiology and Public Health Network (CIBERESP), 28029 Madrid, Spain;
- Departamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, 03550 Alicante, Spain
- Correspondence:
| |
Collapse
|
3
|
Bolourian A, Shen J, Gharagozloo M, Mojtahedi Z. 1Menstruation: a possible independent health promoter, aging and COVID-19. CASPIAN JOURNAL OF INTERNAL MEDICINE 2022; 13:155-160. [PMID: 35872674 PMCID: PMC9272961 DOI: 10.22088/cjim.13.0.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 07/12/2021] [Accepted: 08/22/2021] [Indexed: 11/08/2022]
Abstract
Women live longer than men. Cardiovascular disorders, cancers, and serious infectious conditions are less common among women than men. Recent data also indicate that women, particularly before menopause, are less susceptible to severe COVID-19, a viral infection hitting less-healthy individuals. The superiority of women regarding health has not been completely understood and partly been explained by estradiol beneficial effects on the microenvironment of the body, notably cytokine network. Estradiol cycles are aligned with menstruation cycles, a challenge for distinguishing their individual effects on human health. Large-scale, long-term studies indicate that hysterectomy, particularly at younger ages, is associated with an increased risk of mortality, cancer, or heart disorders. The underlying mechanisms for the increased risk in hysterectomized women are hard to be investigated in animal models since only a few primates menstruate. However, blood exchange models could resemble menstruation and provide some insight into possible beneficial effects of menstruation. Sera from animal models (neutral blood exchange) and also humans that have undergone therapeutic plasma exchange enhance the proliferation of progenitor cells in the culture and contain lower levels of proinflammatory factors. If menstruation resembles a blood exchange model, it can contribute to a healthier cytokine network in women. Consequently, menstruation, independently from estradiol health beneficial effects, can contribute to greater longevity and protection against certain disorders, e.g., COVID-19, in women. Investigation of COVID-19 rate/severity in hysterectomized women will provide insight into the possible beneficial effects of menstruation in COVID-19.
Collapse
Affiliation(s)
- Alireza Bolourian
- College of Pharmacy, Oregon State University, Corvallis, OR, USA,Oregon Health and Science University, Portland, Oregon, USA
| | - Jay Shen
- Department of Health Care Administration and Policy, School of Public Health, University of Nevada, Las Vegas, NV 89154, USA
| | - Marjan Gharagozloo
- Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA
| | - Zahra Mojtahedi
- Department of Health Care Administration and Policy, School of Public Health, University of Nevada, Las Vegas, NV 89154, USA,Autophgy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran,Correspondence: Zahra Mojtahedi, Department of Health Care Administration and Policy, School of Public Health, University of Nevada, Las Vegas, NV 89154, USA. E-mail: , Tel: 0017028955090, Fax: 0017028955090
| |
Collapse
|